Gengxi Cai

6PUBLICATIONS
30CO-AUTHORS
Predictive and prognostic markersCancer geneticsCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|May 07, 2026
The RPS15-DDX21 complex drives prostate malignancy through transcriptional activation of SCD1.

|Nov 03, 2025
WBP11 inhibits UFL1-mediated UFMylation of NONO to drive hepatocellular carcinoma progression.

Hongbiao Huang, Yujie Xiang, Yuanfei Deng

|Nov 03, 2024
The Ku70-SIX1-GPT2 axis regulates alpha-ketoglutarate metabolism to drive progression of prostate cancer.

Hongbiao Huang, Xuefen Zhuang, Shusha Yin

|Jun 30, 2023
Nuclear transport maintenance of USP22-AR by Importin-7 promotes breast cancer progression.

Geng-Xi Cai, Wei-Yao Kong, Yuan Liu

|Jan 13, 2022
Circulating T-Cell Repertoires Correlate With the Tumor Response in Patients With Breast Cancer Receiving Neoadjuvant Chemotherapy.

Gengxi Cai, Zhanwen Guan, Yabin Jin

|Mar 27, 2021
Association between the nucleosome footprint of plasma DNA and neoadjuvant chemotherapy response for breast cancer.

Xu Yang, Geng-Xi Cai, Bo-Wei Han

Pageof 1

Frequent Collaborators

4 joint publications

Yuanfei Deng

3 joint publications

Yujie Xiang

3 joint publications

Yu Yao

3 joint publications

Wenshuang Sun